Evidence map›Paper›PMID 34608382›Full record

ReviewClean technologies and environmental policy2021

The green solvent: a critical perspective.

Neil Winterton

Abstract readReview
In one paragraph

Review in Clean technologies and environmental policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Sustainable Pd-Catalyzed Aminations "on Dirty Water".Angewandte Chemie (International ed. in English) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Machine Learning for Green Solvents: Assessment, Selection and Substitution.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  16. A global analysis of the rise, reign, and retreat of topics in research toward sustainable platform chemicals.Green chemistry : an international journal and green chemistry resource : GC · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Lead Halide Perovskites Nanocrystals Synthesized in a Green, Reusable Solvent.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Neil WintertonDepartment of Chemistry, University of Liverpool, Liverpool, L69 7ZD UK.ORCID 0000-0002-3887-4198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solvents are important in most industrial and domestic applications. The impact of solvent losses and emissions drives efforts to minimise them or to avoid them completely. Since the 1990s, this has become a major focus of green chemistry, giving rise to the idea of the 'green' solvent. This concept has generated a substantial chemical literature and has led to the development of so-called neoteric solvents. A critical overview of published material establishes that few new materials have yet found widespread use as solvents. The search for less-impacting solvents is inefficient if carried out without due regard, even at the research stage, to the particular circumstances under which solvents are to be used on the industrial scale. Wider sustainability questions, particularly the use of non-fossil sources of organic carbon in solvent manufacture, are more important than intrinsic 'greenness'. While solvency is universal, a universal solvent, an alkahest, is an unattainable ideal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10098-021-02188-8.

Indexed as

Research & DevelopmentSolventsSustainable developmentWaste minimisation

Identifiers

PMID34608382
PMCPMC8482956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.